123 related articles for article (PubMed ID: 12355812)
1. [Knockout mouse models for type 2 diabetes. Mice with impaired insulin secretion].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2002 Aug; 60 Suppl 8():58-63. PubMed ID: 12355812
[No Abstract] [Full Text] [Related]
2. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.
Terauchi Y; Iwamoto K; Tamemoto H; Komeda K; Ishii C; Kanazawa Y; Asanuma N; Aizawa T; Akanuma Y; Yasuda K; Kodama T; Tobe K; Yazaki Y; Kadowaki T
J Clin Invest; 1997 Mar; 99(5):861-6. PubMed ID: 9062343
[TBL] [Abstract][Full Text] [Related]
3. [Transgenic mouse model of type 2 diabetes mellitus with insulin secretion insufficient].
Hosoda K; Son C; Fujikura J; Iwakura H; Tomita T; Nakao K
Nihon Rinsho; 2002 Aug; 60 Suppl 8():75-8. PubMed ID: 12355840
[No Abstract] [Full Text] [Related]
4. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose-induced insulin secretion: studies in animal models with spontaneous NIDDM.
Ostenson CG; Khan A; Efendic S
Adv Exp Med Biol; 1993; 334():1-11. PubMed ID: 8249675
[No Abstract] [Full Text] [Related]
6. The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion.
Horio F; Teradaira S; Imamura T; Anunciado RV; Kobayashi M; Namikawa T; Niki I
Eur J Endocrinol; 2005 Dec; 153(6):971-9. PubMed ID: 16322404
[TBL] [Abstract][Full Text] [Related]
7. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
Hamada Y; Ikegami H; Ueda H; Kawaguchi Y; Yamato E; Nojima K; Yamada K; Babaya N; Shibata M; Ogihara T
Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045
[TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance in young TallyHo mice is induced by leptin-mediated inhibition of insulin secretion.
Sung YY; Lee YS; Jung WH; Kim HY; Cheon HG; Yang SD; Rhee SD
Biochem Biophys Res Commun; 2005 Dec; 338(4):1779-87. PubMed ID: 16288988
[TBL] [Abstract][Full Text] [Related]
10. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.
Bailey CJ; Flatt PR
Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():43S-50S. PubMed ID: 8299488
[No Abstract] [Full Text] [Related]
11. [Impaired insulin secretion in isolated islets of Goto-Kakizaki rats, an animal model of non obese type 2 diabetes, is a primary event].
Seiça RM; Suzuki KI; Santos RM; Do Rosário LM
Acta Med Port; 2004; 17(1):42-8. PubMed ID: 15636726
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis.
Cooksey RC; Jouihan HA; Ajioka RS; Hazel MW; Jones DL; Kushner JP; McClain DA
Endocrinology; 2004 Nov; 145(11):5305-12. PubMed ID: 15308612
[TBL] [Abstract][Full Text] [Related]
13. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
Guillam MT; Hümmler E; Schaerer E; Yeh JI; Birnbaum MJ; Beermann F; Schmidt A; Dériaz N; Thorens B
Nat Genet; 1997 Nov; 17(3):327-30. PubMed ID: 9354799
[TBL] [Abstract][Full Text] [Related]
14. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
15. [Molecular pathogenesis of type 2 diabetes mellitus].
Kadowaki T
Seikagaku; 1999 Nov; 71(11):1281-98. PubMed ID: 10614177
[No Abstract] [Full Text] [Related]
16. Beta cell dysfunction in non-insulin-dependent diabetes mellitus.
Gray H; O'Rahilly S
Transplant Proc; 1994 Apr; 26(2):366-70. PubMed ID: 8171465
[No Abstract] [Full Text] [Related]
17. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.
Gunton JE; Kulkarni RN; Yim S; Okada T; Hawthorne WJ; Tseng YH; Roberson RS; Ricordi C; O'Connell PJ; Gonzalez FJ; Kahn CR
Cell; 2005 Aug; 122(3):337-49. PubMed ID: 16096055
[TBL] [Abstract][Full Text] [Related]
18. PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells.
Hashimoto N; Kido Y; Uchida T; Matsuda T; Suzuki K; Inoue H; Matsumoto M; Ogawa W; Maeda S; Fujihara H; Ueta Y; Uchiyama Y; Akimoto K; Ohno S; Noda T; Kasuga M
J Clin Invest; 2005 Jan; 115(1):138-45. PubMed ID: 15630453
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.
Ueda K; Tanizawa Y; Ishihara H; Kizuki N; Ohta Y; Matsutani A; Oka Y
Diabetologia; 1998 Jun; 41(6):649-53. PubMed ID: 9662045
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both?
Glaser B
PLoS Med; 2007 Apr; 4(4):e148. PubMed ID: 17407388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
